Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Restructuring nephrology services to combat COVID-19 pandemic: Report from a Middle Eastern country
Muhammad Asim, Mohamad Alkadi, Abdullah Hamad, Muftah Othman, Essa Abuhelaiqa, Omar Fituri, Ihab El-Madhoun, Hassan Al-Malki, Nephrology Division, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar
Author contributions: Asim M conceived the presented idea, structured the manuscript, and designed the figures; All authors were involved in acquisition of data, drafting the manuscript and revising it critically for important intellectual content.
Conflict-of-interest statement: The authors declare no potential conflicts of interest in relation to this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Muhammad Asim, BSc, FRCP, MBBS, Associate Professor, Nephrology Division, Department of Medicine, Hamad Medical Corporation, Al-Rayan Street, Doha 3050, Qatar. masim@hamad.qa
Received: July 23, 2020
Peer-review started: July 23, 2020
First decision: October 21, 2020
Revised: October 26, 2020
Accepted: November 4, 2020
Article in press: November 4, 2020
Published online: November 29, 2020
Peer-review started: July 23, 2020
First decision: October 21, 2020
Revised: October 26, 2020
Accepted: November 4, 2020
Article in press: November 4, 2020
Published online: November 29, 2020
Core Tip
Core Tip: Although the impact of the pandemic and the healthcare models differ across countries, pandemic preparedness planning is vital to improve the effectiveness of a country’s response to the pandemic. Renal replacement therapy is a lifesaving treatment, and it is imperative that healthcare systems invest in technical infrastructure, staff, and supplies to provide efficient critical care nephrology services in the setting of a pandemic.